Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 3, keine Gesamtzahl für „thalidomide“
Suchtreffer
Begriffe & Kennungen
Thalidomide BMS (previously Thalidomide Celgene) · 4.8 · Most patients taking thalidomide can be expected to experience adverse reactions. The most commonly observed a
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Neutropenia, Leukopenia, Anaemia, Lymphopenia, Blood and lymphatic system Very Common Thrombocytopenia disorde
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Peripheral neuropathy Peripheral neuropathy is a very common, potentially severe, adverse reaction of treatmen
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Posterior reversible encephalopathy syndrome (PRES)/Reversible posterior leukoencephalopathy syndrome (RPLS) C
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Summary of the safety profile
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · System Organ Class Frequency Adverse reaction
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Table 3 contains only the adverse reactions for which a causal relationship with medicinal product treatment c
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Table 3: Adverse drug reactions (ADRs) reported in pivotal clinical study with thalidomide in combination with
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Teratogenicity The risk of intra-uterine death or severe birth defects, primarily phocomelia, is extremely hig
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · The adverse reaction profile reported in patients > 75 years of age treated with thalidomide 100 mg once daily
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · The most clinically important adverse reactions associated with the use of thalidomide in combination with mel
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Venous and arterial thromboembolic events An increased risk of venous thromboembolism (such as deep vein throm
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · untreated MM receiving the combination of melphalan, prednisone and thalidomide (MPT)
Eintrag öffnenthalidomide
Eintrag öffnenthalidomide
Eintrag öffnen